What problem does this paper attempt to address?

According to the provided text content, the correction statement of this paper does not elaborate on the problems that the original paper attempted to solve. However, the main problems of this research can be inferred from the title and author information. ### Problems the paper attempted to solve The title of the original paper is "Synthetic ramoplanin analogues are accessible by effective incorporation of arylglycines in solid - phase peptide synthesis". From this title, it can be seen that this research mainly attempted to solve the following problems: 1. **Develop a new synthesis method**: The researchers hoped to develop an effective method to synthesize analogues of ramoplanin by introducing arylglycines in the solid - phase peptide synthesis process. Ramoplanin is a cyclic lipopeptide antibiotic with antibacterial activity, and its synthesis and structural modification are of great significance for drug development. 2. **Improve synthesis efficiency and accuracy**: By introducing arylglycines, the researchers aimed to improve the efficiency and accuracy in the synthesis process, so as to better control the structural and functional characteristics of the final product. 3. **Structure verification and optimization**: Ensure that the synthesized ramoplanin analogues have the correct three - dimensional structure and can maintain or enhance their antibacterial activity. This is also reflected in the correction of the NOE (nuclear - nuclear Overhauser effect in nuclear magnetic resonance) data mentioned in the original text, that is, to ensure the precision of the structure (for example, backbone RMSD = 0.17 Å, heavy - atom RMSD = 0.49 Å). ### Correction content The correction statement points out that the original paper had an error in the number of distance constraints when describing the final structure set. Specifically, the original paper incorrectly stated the number of distance constraints used to obtain the final structure set. The correct content should be: > "The final structure set is based on 330 assigned NOEs (see Table S3 and Figure S6), including 104 long - range NOEs, and has good precision (backbone RMSD = 0.17 Å, heavy - atom RMSD = 0.49 Å), as well as residual constraint violations." This correction ensures the accuracy and reliability of the structural data, thus supporting the validity of the research results. ### Summary The core problem of this paper is to develop an efficient and accurate solid - phase peptide synthesis method to synthesize ramoplanin analogues with antibacterial activity, and verify the accuracy of their structures through techniques such as nuclear magnetic resonance. The correction statement further ensures the reliability of these structural data.

Correction: Synthetic ramoplanin analogues are accessible by effective incorporation of arylglycines in solid-phase peptide synthesis

Correction to “highly Diastereoselective Synthesis of Tetrahydropyridines by a C–H Activation–Cyclization–Reduction Cascade”

Corrigendum to “synthesis and in Vitro Pharmacological Studies of New C(4) Modified Salvinorin A Analogues” [bioorg. Med. Chem. Lett. 16 (2006) 5498–5502]

Correction: The multifaceted nature of antimicrobial peptides: current synthetic chemistry approaches and future directions

Correction: Supramolecularly Engineered Phospholipids Constructed by Nucleobase Molecular Recognition: Upgraded Generation of Phospholipids for Drug Delivery

Correction: Facile Preparation of Phospholipid-Amorphous Calcium Carbonate Hybrid Nanoparticles: Toward Controllable Burst Drug Release and Enhanced Tumor Penetration.

Correction: Synthesis, docking and biological evaluation of purine-5-N-isosteres as anti-inflammatory agents

Correction: Synthesis of C14–C21 acid fragments of cytochalasin Z<sub>8</sub><i>via anti</i>-selective aldol condensation and <i>B</i>-alkyl Suzuki–Miyaura cross-coupling

Correction: A zinc–porphyrin–peptide conjugate via "click-chemistry": synthesis and amyloid-β interaction

Correction: Convergent synthesis of thiodiazole dioxides from simple ketones and amines through an unusual nitrogen-migration mechanism

Corrections to "An Optimized Safe Process from Bench to Pilot cGMP Production of API Eptifibatide Using a Multigram-Scale Microwave-Assisted Solid-Phase Peptide Synthesizer"

Correction: Synthesis and anticancer evaluation of [ d -Ala]-nocardiotide A

Correction: Design and synthesis of eugenol/isoeugenol glycoconjugates and other analogues as antifungal agents against Aspergillus fumigatus

Correction to Synthesis and Application of Enantioenriched Functionalized Α-Tetrasubstituted Α-Amino Acids from Biocatalytic Desymmetrization of Prochiral Α-Aminomalonamides

Correction to "The Quest for Secondary Pharmaceuticals: Drug Repurposing/Chiral-Switches Combination Strategy"

Corrigendum: Identification of novel anti-amoebic pharmacophores from kinase inhibitor chemotypes

Correction: Cu-catalyzed Arylation of S-tosyl Peptides with Arylboronic Acids

Correction and Removal of Expression of Concern: Highly stereoselective gram scale synthesis of all the four diastereoisomers of Boc-protected 4-methylproline carboxylates

Correction: Scalable synthesis and structural characterization of reversible KLK6 inhibitors

Correction to "Process Development for 6-Aminopenicillanic Acid Production Using Lentikats-Encapsulated Escherichia coli Cells Expressing Penicillin V Acylase"

Correction: Wu et al. Synthesis of Spirooxindole-O-Naphthoquinone-Tetrazolo[1,5-a]Pyrimidine Hybrids as Potential Anticancer Agents. Molecules 2018, 23, 2330